41
Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine
Condition(s): Diphtheria; Tetanus; Whooping Cough; Hepatitis B; Poliovirus; Haemophilus Influenzae Type b Disease Last Updated: April 9, 2009Completed
618 Clinical Trials for: Biological VAQTA®, Page 3 of 31
Hide Studies Not Seeking New Volunteers
42
Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.
Condition(s): Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meningitidis Vaccines; Tetanus Last Updated: November 16, 2012Terminated
43
Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
Condition(s): Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus Last Updated: April 25, 2013Completed
44
Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix-HepB/Hib Compared to GSK Vaccine Tritanrix-HepB/Hiberix
Condition(s): Hepatitis B; Diphtheria; Pertussis; Haemophilus Influenzae Type b Diseases; Tetanus Last Updated: November 17, 2011Completed
45
Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients
Condition(s): Hepatitis C Last Updated: September 10, 2012Not yet recruiting
46
Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study
Condition(s): Hib Disease; Hepatitis B; Diphtheria; Pertussis; Neisseria Meningitidis Serogroup Diseases; Tetanus Last Updated: November 3, 2011Completed
47
Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
Condition(s): Child Health Last Updated: April 25, 2012Active, not recruiting
48
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
Condition(s): Chronic Hepatitis B Last Updated: October 17, 2012Active, not recruiting
49
Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age
Condition(s): Measles-Mumps-Rubella-Varicella Vaccine; Diseases Caused by Measles, Mumps, Rubella and Varicella Viruses. Last Updated: January 31, 2013Completed
50
Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18
Condition(s): Human Papillomavirus (HPV) Infection; Cervical Neoplasia Last Updated: February 23, 2012Completed
51
Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age
Condition(s): Poliomyelitis; Hepatitis B; Diphtheria; Haemophilus Influenzae Type b; Pertussis; Pneumococcal Diseases; Serogroup C Meningococcal; Rotavirus; Tetanus Last Updated: December 8, 2011Completed
52
LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers
Condition(s): Hepatitis B Last Updated: February 17, 2011Completed
53
Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared
Condition(s): Hepatitis B; Hepatitis A Last Updated: November 10, 2011Completed
54
Long-Term Follow-Up Studies at Year 6, 7, 8, 9, 10: 2 Formulations of Combined Hepatitis A/B Vaccine Compared in Subjects Aged 12-15 Years
Condition(s): Hepatitis B; Hepatitis A Last Updated: November 3, 2011Completed
55
Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine
Condition(s): Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Pneumococcal Diseases; Tetanus Last Updated: February 24, 2011Withdrawn
56
Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants
Condition(s): Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Pneumococcal Diseases; Tetanus Last Updated: May 2, 2013Completed
57
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose
Condition(s): Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Serogroup C Meningococcal Diseases; Diphtheria; Pertussis; Tetanus Last Updated: December 1, 2011Completed
58
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
Condition(s): Poliomyelitis; Haemophilus Influenzae Type b Disease; Hepatitis B; Diphtheria; Pertussis; Tetanus Last Updated: May 2, 2013Completed
59
Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 Years
Condition(s): Hepatitis B Last Updated: October 2, 2006Completed
60
Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules
Condition(s): Hepatitis B Last Updated: June 11, 2008Completed
